Letairis and Ofloxacin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Letairis and Ofloxacin together.

The phase IV clinical study analyzes what interactions people who take Letairis and Ofloxacin have. It is created by eHealthMe based on reports of 4 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 07, 2022

4 people who take Letairis and Ofloxacin together, and have interactions are studied.


What is Letairis?

Letairis has active ingredients of ambrisentan. It is often used in pulmonary hypertension. eHealthMe is studying from 92,601 Letairis users for its effectiveness, alternative drugs and more.

What is Ofloxacin?

Ofloxacin has active ingredients of ofloxacin. It is often used in urinary tract infection. eHealthMe is studying from 7,805 Ofloxacin users for its effectiveness, alternative drugs and more.

Number of Letairis and Ofloxacin reports submitted per year:

Letairis and Ofloxacin drug interactions.

Common Letairis and Ofloxacin drug interactions by gender *:

female:

  1. Cardio-respiratory arrest
  2. Chronic kidney disease
  3. Left ventricular failure
  4. Tricuspid valve incompetence

male:

  1. Asthenia
  2. Cholelithiasis
  3. Pneumonia
  4. Tinnitus
  5. Ear discomfort
  6. Fall
  7. Inguinal hernia
  8. Muscle spasms
  9. Musculoskeletal stiffness
  10. Nasopharyngitis

Common Letairis and Ofloxacin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Asthenia
  2. Cardio-respiratory arrest
  3. Nocturnal dyspnoea
  4. Oxygen saturation decreased
  5. Pneumonia
  6. Tricuspid valve incompetence
  7. Cholelithiasis
  8. Chronic kidney disease
  9. Fall
  10. Inguinal hernia

* Approximation only. Some reports may have incomplete information.

Do you take Letairis and Ofloxacin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Letairis and Ofloxacin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Letairis side effects:

Browse all side effects of Letairis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ofloxacin side effects:

Browse all side effects of Ofloxacin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Letairis interactions:

Browse all interactions between Letairis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ofloxacin interactions:

Browse all interactions between Ofloxacin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ambrisentan and ofloxacin (the active ingredients of Letairis and Ofloxacin, respectively), and Letairis and Ofloxacin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Letairis and Ofloxacin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: